基本信息 产品详情 公司简介 推荐产品
网站主页 SLAMF7蛋白 SLAMF7蛋白
  • 重组人SLAMF7/CRACC/CD319蛋白, His Tag
  • 重组人SLAMF7/CRACC/CD319蛋白, His Tag
  • 重组人SLAMF7/CRACC/CD319蛋白, His Tag

1/3

重组人SLAMF7/CRACC/CD319蛋白, His Tag

SLAMF7
询价 100ug 起订
500ug 起订
1000ug 起订
北京 更新日期:2025-11-06

北京百普赛斯生物科技股份有限公司

VIP2年
联系人:赵先生
手机:13121935750 拨打
邮箱:jiaxin.zhao@acrobiosystems.com

产品详情:

中文名称:
SLAMF7蛋白
英文名称:
SLAMF7
品牌:
百普赛斯
产地:
北京
保存条件:
-20°C to -70°C
纯度规格:
99.9%
产品类别:
重组蛋白
货号:
SLAMF7
用途范围:
科研
规格:
100ug
是否进口:

PE-Labeled Human SLAMF7 / CRACC / CD319 Protein, His Tag

分子别名(Synonym

SLAMF7,CD319,CS1,CRACC,19A,FOAP-12

表达区间及表达系统(Source

PE-Labeled Human SLAMF7 Protein, His Tag (SL7-HP2H6) is produced via conjugation of PE to Human SLAMF7 Protein, His Tag with a new generation site-specific technology under Star Staining labeling platform. Human SLAMF7 Protein, His Tag is expressed from human 293 cells (HEK293). It contains AA Ser 23 - Met 226 (Accession # AAH27867).

Predicted N-terminus: Ser 23

蛋白结构(Molecular Characterization

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 36.9 kDa.

偶联(Conjugate

PE

Excitation Wavelength: 488 nm / 561 nm

Emission Wavelength: 575 nm

纯度(Purity

>90% as determined by SDS-PAGE.

制剂(Formulation

Lyophilized from 0.22 μm filtered solution in PBS, 0.2% BSA, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please protect from light and avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 12 months in lyophilized state;

-70°C for 3 months under sterile conditions after reconstitution.

1.jpg

背景介绍

CLEC12A (C-type lectin domain family 12 member A) is also known as CLL1, DCAL2, MICL. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death. Cell surface receptor that modulates signaling cascades and mediates tyrosine phosphorylation of target MAP kinases. Evidence of distinct disease propagating stem cells in myelodysplastic syndrome (MDS) has emerged in recent years. The role of CLEC12A in MDS, however, remains to be elucidated. Furthermore, CLEC12A has been proposed as a promising marker of leukaemic stem cells in AML.

SLAMF7;SLAMF7蛋白;SLAMF7重组蛋白;ACRO;百普赛斯;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。

成立日期 (16年)
注册资本 8000万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药

SLAMF7蛋白相关厂家报价

内容声明
拨打电话 立即询价